Emily Pimblett, SVP, Finance & CAO at Climb Bio, Inc. (CLYM), sold 1,199 shares at $1.31 ($2K) on 2025-03-20, disclosed to the SEC on 2025-03-20.
Scheduled sale ($2k) by SVP, Finance & CAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ELYM | SELL | 2024-09-20 | $10K | — | Filing → |
| ELYM | SELL | 2024-06-21 | $9K | — | Filing → |